|
India, Canada To Launch R&D Projects In Biotech, Medical
Devices
Under the Canada-india Agreement for Scientific and
Technological Cooperation aimed at fostering joint Research and Development
(R&D) projects, the two sides will launch R&D projects in all areas of
biotechnology including life sciences and medical devices.
The Ontario-India programme has now called for proposals for
collaborative projects with a view to develop innovative products especially in
the life science and medical devices sectors. It aims to stimulate innovative
R&D projects (engaging small-to-medium-sized companies and/or larger, well
established firms) that address a specific market need or challenge; demonstrate
high industrial relevance and commercial potential; and aim to deliver benefit
to all participants, and more broadly, to both nations. These projects help
participants to become more competitive by developing global researchbased
alliances with the potential to foster increased or expanded international R&D
collaboration, said the note from the Department of Biotechnology.
The projects will be delivered through the DBT on the Indian
side and International Science and Technology Partnerships Canada (ISTPCanada),
a nongovernmental organization selected by the Ministry of Research and
Innovation (MRI), Government of Ontario on the Canadian side. In Ontario
(Canada), ISTPCanada is responsible for the implementation of the Ontario/India
Collaborative Research Fund, Which directly supports four goals established by
the Government of Ontario.
Researchers and managers of Indian Companies, academic
institutions, research hospitals or other R&D institutions (including
not-for-profit research institutes recognized by DBT) have been asked to send in
the expression of interest.
The projects, with a duration upto 24 months, must be
innovative and market-driven, leading to the proposed development of a new
product or process leading to commercialization. Selected Ontario (Canada)-India
R&D project participants will receive funding from MRI in Canada and DBT in
India. Funds will be provided in accordance with the national laws, rules,
regulations and procedures established by each organization, and/or each
jurisdiction/country.
(Ref: Chronicle Pharmabiz, July 7, 2011)
|
